Monte Rosa Therapeutics Inc
Research Monte Rosa Therapeutics Inc (GLUE) on Bullrun: market cap USD 896.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGLUE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 896.58M
- Financial periodQ2 2026
- RevenueUSD 8.97M
- Net income-USD 43.40M
- Free cash flow-USD 48.84M
Valuation Snapshot
latest market cap is USD 896.58M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 123.67M | -USD 38.60M | -USD 27.50M | n/a | -0.59 | USD 129.88M | USD 39.19M | USD 233.06M |
| FY2024 | USD 75.62M | -USD 72.70M | USD 38.01M | n/a | -1.18 | USD 224.25M | USD 42.72M | USD 222.94M |
| FY2023 | USD 0 | -USD 135.35M | -USD 62.84M | n/a | -2.63 | USD 128.10M | USD 46.04M | USD 179.25M |
| FY2022 | USD 0 | -USD 108.50M | -USD 105.38M | n/a | -2.3 | USD 54.91M | USD 47.00M | USD 271.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 896.58M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.03B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 426.86M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 282.96M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 368.32M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 950.27M | n/a | n/a | n/a |
About Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Monte Rosa Therapeutics Inc's market cap?
Monte Rosa Therapeutics Inc's market capitalization is USD 896.58M.
What does Monte Rosa Therapeutics Inc do?
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins.